CA, P., BA, A., M, V., LE, R., & ES, S. (2012). Emerging role of multikinase inhibitors for refractory thyroid cancer. Dove Medical Press.
Cita Chicago Style (17a ed.)CA, Perez, Arango BA, Velez M, Raez LE, y Santos ES. Emerging Role of Multikinase Inhibitors for Refractory Thyroid Cancer. Dove Medical Press, 2012.
Cita MLA (8a ed.)CA, Perez, et al. Emerging Role of Multikinase Inhibitors for Refractory Thyroid Cancer. Dove Medical Press, 2012.
Precaución: Estas citas no son 100% exactas.